RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: limb ischemia
Accession: DOID:0050852
browse the term
Definition: An ischemia that is characterized by low blood supply to tissues in the limb due to interruption in the arterial blood supply. (DO)
G
Agtr1a
angiotensin II receptor, type 1a
IMP
RGD
PMID:11877468
RGD:737810
NCBI chr13:30,520,339...30,566,850
Ensembl chr13:30,520,424...30,566,850
G
Aldh1a2
aldehyde dehydrogenase family 1, subfamily A2
IMP
RGD
PMID:26315408
RGD:14367880
NCBI chr 9:71,123,071...71,203,525
Ensembl chr 9:71,123,071...71,203,525
G
Cs
citrate synthase
ISO
RGD
PMID:571116
RGD:243049254
NCBI chr10:128,173,596...128,198,351
Ensembl chr10:128,173,603...128,198,348
G
Csf2
colony stimulating factor 2 (granulocyte-macrophage)
IEP
protein:increased expression:plasma:
RGD
PMID:16648859
RGD:10449511
NCBI chr11:54,138,096...54,140,725
Ensembl chr11:54,138,097...54,140,493
G
Csf3
colony stimulating factor 3 (granulocyte)
treatment
ISO
RGD
PMID:23294128 PMID:16224058
RGD:10400895 , RGD:11039414
NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
G
Dll4
delta like canonical Notch ligand 4
exacerbates ameliorates
IMP ISO
RGD
PMID:20508179 PMID:35301145 PMID:22252294
RGD:155641249 , RGD:155663375 , RGD:155663358
NCBI chr 2:119,156,286...119,166,145
Ensembl chr 2:119,156,265...119,166,443
G
Epo
erythropoietin
treatment
ISO
RGD
PMID:23294128
RGD:10400895
NCBI chr 5:137,481,282...137,484,078
Ensembl chr 5:137,481,282...137,531,504
G
Etv2
ets variant 2
exacerbates ameliorates
IMP ISO IDA
RGD
PMID:26586661 PMID:28466428 PMID:32075417 PMID:28424975 PMID:28424975
RGD:11076207 , RGD:192379484 , RGD:192186227 , RGD:156451664 , RGD:156451664
NCBI chr 7:30,333,041...30,335,934
Ensembl chr 7:30,333,041...30,335,277
G
Fgfr1
fibroblast growth factor receptor 1
treatment
ISO
RGD
PMID:25388665
RGD:11568031
NCBI chr 8:26,008,808...26,067,819
Ensembl chr 8:26,003,670...26,065,734
G
Grk2
G protein-coupled receptor kinase 2
treatment
ISO
RGD
PMID:26604244
RGD:13514042
NCBI chr19:4,336,029...4,356,356
Ensembl chr19:4,336,029...4,356,250
G
Hgf
hepatocyte growth factor
treatment
ISO
RGD
PMID:15238569
RGD:8548639
NCBI chr 5:16,758,493...16,827,448
Ensembl chr 5:16,758,493...16,825,150
G
Hif1a
hypoxia inducible factor 1, alpha subunit
ISO
protein:increased expression:skeletal muscle
RGD
PMID:17522350
RGD:1626332
NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304
G
Hmox1
heme oxygenase 1
ISO
RGD
PMID:12593860
RGD:1598394
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Itgam
integrin alpha M
ISO
protein:increased expression:monocyte (human)
RGD
PMID:20816321
RGD:329901827
NCBI chr 7:127,661,812...127,717,663
Ensembl chr 7:127,661,812...127,717,663
G
Itgav
integrin alpha V
IEP
RGD
PMID:15750161
RGD:1582449
NCBI chr 2:83,554,796...83,637,261
Ensembl chr 2:83,554,741...83,637,260
G
Mir126a
microRNA 126a
ameliorates
IDA IMP
associated with type 1 diabetes mellitus;
RGD
PMID:29242072 PMID:35151721
RGD:401851035 , RGD:401851044
NCBI chr 2:26,481,369...26,481,441
Ensembl chr 2:26,481,369...26,481,441
G
Mir210
microRNA 210
severity
IMP
RGD
PMID:31878120
RGD:155882482
NCBI chr 7:140,801,297...140,801,406
Ensembl chr 7:140,801,297...140,801,406
G
Nos3
nitric oxide synthase 3, endothelial cell
treatment
ISO
associated with Diabetes Mellitus, Experimental human gene in rat model
RGD
PMID:19080171 PMID:12171788 PMID:28979692
RGD:7794710 , RGD:7794776 , RGD:13450931
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
G
Pecam1
platelet/endothelial cell adhesion molecule 1
IDA
RGD
PMID:22369073 PMID:21940947
RGD:6767285 , RGD:6906905
NCBI chr11:106,545,039...106,606,107
Ensembl chr11:106,545,043...106,641,454
G
Ppbp
pro-platelet basic protein
ISO
protein:increased expression:plasma
RGD
PMID:30638058
RGD:401794451
NCBI chr 5:90,916,377...90,917,922
Ensembl chr 5:90,916,377...90,917,922
G
Ptgis
prostaglandin I2 (prostacyclin) synthase
treatment
ISO
human gene in a mouse model rat gene in human cells in a mouse model
RGD
PMID:12586736 PMID:14568901 PMID:19344900
RGD:401959585 , RGD:401960079 , RGD:401960096
NCBI chr 2:167,045,114...167,095,069
Ensembl chr 2:167,033,725...167,082,524
G
Ptpn1
protein tyrosine phosphatase, non-receptor type 1
IEP
protein:increased expression, increased activity:hindlimb muscle (mouse)
RGD
PMID:18451337
RGD:401965417
NCBI chr 2:167,772,670...167,821,305
Ensembl chr 2:167,773,977...167,821,305
G
Vegfa
vascular endothelial growth factor A
treatment
ISO
RGD
PMID:23562340
RGD:7421600
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
G
Gpt
glutamic pyruvic transaminase, soluble
treatment
ISO
RGD
PMID:36495512
RGD:401717522
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all